title: Abiraterone plus prednisone improves survival in metastatic castration-resistant prostate cancer.
authors.affiliation: Department of Medicine, Weill Cornell Medical College, Weill Cornell Cancer Center, New York, NY 10065, USA. stt2007@med.cornell.edu
authors.forename: Scott T
authors.initials: ST
authors.lastname: Tagawa
authors.forename: Himisha
authors.initials: H
authors.lastname: Beltran
mesh_terms: D000736:Androstenes; D000737:Androstenols / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D009919:Orchiectomy; D011241:Prednisone / Q000008:administration & dosage; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
chemical_list: D000736:Androstenes; D000737:Androstenols; D004791:Enzyme Inhibitors; C089740:abiraterone; D011241:Prednisone